MarketCap
Facebook
X
Telegram
Healthcare Services Group Financial Ratios 2025-2007 | HCSG
Brief overview of Healthcare Services Group's market valuation
Current figures are compared with the company's own five-year history for 2021–2025.
The latest available valuation ratios are P/E 26.34x (median 26.34x), EV/EBITDA 86.99x (median 29.37x), P/S 0.85x (median 0.63x). The current ratio basket stands about 31.8% above the five-year base, increasing sensitivity to weak reports.
At the current P/E, inverse earnings yield is 3.8%, a useful bridge between price and business earnings.
Returns on assets and capital are represented by ROE 11.6%, ROA 7.4%, ROCE 13.6%. Return ratios are at workable levels. The business generates positive returns, though efficiency is not exceptional.
PEG is 6.27x. Price is well ahead of embedded growth, making market expectations demanding.
A longer cycle, from -15.1 days to 42.7 days, indicates slower release of cash from operations.
What the ratios show
Healthcare Services Group's high quality ratios explain part of the market premium but increase sensitivity to slower growth.
Annual Financial Ratios Healthcare Services Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
26.3 | 20.3 | 23.7 | 31.3 | 28.0 | 24.0 | 29.9 | 38.5 | 45.0 | 37.2 | 43.8 | 101.8 | 40.1 | 36.9 | 32.3 | 25.5 | 26.6 | 28.1 | - |
P/S |
0.8 | 0.5 | 0.5 | 0.6 | 0.8 | 1.3 | 1.1 | 1.6 | 2.1 | 1.8 | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 211.6 | - | - | - |
EPS |
0.8 | 0.5 | 0.5 | 0.5 | 0.7 | 1.3 | 0.9 | 1.1 | 1.2 | 1.1 | 0.8 | 0.3 | 0.7 | 0.7 | 0.6 | 0.5 | 0.5 | 0.4 | - |
EV (Enterprise Value) |
1.43 B | 745 M | 855 M | 1.04 B | 1.29 B | 2.23 B | 2.17 B | 3.44 B | 4.23 B | 3.05 B | 2.69 B | 2.34 B | 1.97 B | 1.66 B | 1.27 B | 837 M | 776 M | 710 M | -92.5 M |
EBITDA per Share |
0.23 | 0.2 | 0.19 | 0.21 | 0.2 | 0.19 | 1.23 | 1.48 | 1.85 | 1.72 | 1.35 | 0.529 | 0.997 | 1.07 | 0.918 | 0.06 | 0.05 | 0.04 | - |
EV/EBITDA |
85.2 | 51.1 | 59.6 | 68.2 | 87.0 | 17.4 | 20.9 | 29.4 | 29.4 | 22.8 | 25.9 | 57.6 | 26.5 | 21.6 | 19.5 | 222.5 | 240.3 | 248.9 | - |
PEG |
6.27 | -1.29 | -1.18 | -1.41 | -1.29 | -1.4 | -1.29 | -6.59 | 3.4 | 1.21 | 0.27 | -1.87 | 10.47 | 2.48 | 3.36 | - | - | - | - |
P/B |
2.0 | 1.0 | 1.2 | 1.5 | 1.7 | 3.0 | 4.2 | 7.3 | 9.9 | 8.5 | 8.6 | 8.1 | 6.6 | 7.1 | 5.7 | 3.2 | 3.0 | - | - |
P/CF |
10.7 | 26.0 | 20.9 | -131.2 | 36.7 | 10.9 | 21.7 | 42.8 | 1776.6 | 80.1 | 43.5 | 42.8 | 66.6 | 28.7 | 45.0 | 23.2 | 21.1 | 44.9 | - |
ROE % |
11.58 | 7.90 | 8.41 | 8.19 | 10.90 | 20.54 | 14.03 | 18.95 | 22.06 | 22.84 | 19.57 | 7.92 | 16.53 | 19.26 | 17.52 | 16.16 | 14.53 | 13.20 | - |
ROA % |
7.44 | 4.92 | 4.85 | 4.75 | 6.22 | 12.57 | 8.94 | 12.06 | 13.05 | 14.65 | 12.06 | 4.65 | 11.08 | 13.35 | 13.17 | 12.39 | 11.41 | - | - |
ROCE % |
- | - | - | - | - | - | 13.57 | 18.94 | 25.80 | 27.54 | 23.14 | 8.55 | 19.25 | 25.56 | 23.25 | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | 3.5 | 3.1 | 2.9 | 4.1 | 3.8 | 2.8 | 3.1 | 4.0 | 5.1 | - | - | - | - |
DSO |
60.8 | 71.9 | 37.7 | - | - | - | 67.6 | 62.1 | 74.1 | 63.4 | 54.6 | 55.9 | 60.0 | 47.5 | 53.7 | - | - | - | - |
DIO |
- | - | - | - | - | - | 8.3 | 8.5 | 9.6 | 10.3 | 10.7 | 11.2 | 11.9 | 11.2 | 12.0 | - | - | - | - |
DPO |
18.1 | 20.2 | 19.0 | 16.2 | 15.1 | 13.0 | 12.3 | 12.7 | 16.9 | 11.7 | 12.2 | 13.8 | 16.0 | 8.9 | 5.1 | - | - | - | - |
Operating Cycle |
60.8 | 71.9 | 37.7 | - | - | - | 75.9 | 70.6 | 83.7 | 73.7 | 65.3 | 67.1 | 71.9 | 58.7 | 65.6 | - | - | - | - |
Cash Conversion Cycle |
42.7 | 51.7 | 18.7 | -16.2 | -15.1 | -13.0 | 63.6 | 58.0 | 66.8 | 62.0 | 53.1 | 53.4 | 55.9 | 49.8 | 60.6 | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Healthcare Services Group
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.33 | 0.37 | - | 0.59 | -0.44 | 0.23 | - | 0.19 | -0.02 | 0.21 | - | -0.07 | 0.11 | 0.16 | - | - | 0.09 | 0.15 | - | 0.13 | 0.13 | 0.33 | - | 0.37 | 0.31 | 0.27 | 0.25 | 0.25 | 0.24 | 0.12 | 0.43 | 0.35 | 0.35 | - | 0.27 | 0.32 | 0.31 | 0.3 | 0.28 | 0.27 | 0.26 | 0.26 | 0.13 | 0.24 | 0.23 | 0.22 | 0.22 | -0.31 | 0.2 | 0.21 | 0.08 | 0.2 | 0.19 | 0.22 | 0.19 | 0.17 | 0.17 | 0.13 | 0.16 | 0.15 | 0.15 | 0.12 | 0.21 | 0.2 |
EBITDA per Share |
0.11 | 0.05 | - | 0.05 | 0.04 | 0.05 | - | 0.04 | 0.04 | 0.05 | - | 0.03 | 0.03 | 0.05 | - | 0.03 | 0.03 | 0.06 | - | 0.15 | 0.03 | 0.05 | - | 0.14 | 0.1 | 0.05 | - | 0.14 | 0.09 | 0.05 | - | 0.09 | 0.07 | 0.03 | - | 0.09 | 0.06 | 0.03 | - | 0.08 | 0.05 | 0.03 | - | 0.08 | 0.05 | 0.03 | - | 0.08 | 0.05 | 0.02 | - | 0.06 | 0.04 | 0.02 | - | 0.06 | 0.04 | 0.02 | - | 0.05 | 0.03 | 0.02 | 0.06 | 0.04 |
ROE % |
11.32 | 10.30 | 5.23 | 8.10 | -0.94 | 9.07 | 5.72 | 4.55 | 3.55 | 6.63 | 3.41 | 3.48 | 6.21 | 6.87 | 4.17 | 6.16 | 8.04 | 11.48 | 8.95 | 14.70 | 17.52 | 19.76 | 14.76 | 18.87 | 17.10 | 16.24 | 14.11 | 17.16 | 19.10 | 21.00 | 18.95 | 16.84 | 16.79 | 16.57 | 22.06 | 23.00 | 22.95 | 22.85 | 22.84 | 19.93 | 19.88 | 19.84 | 19.57 | 22.10 | 8.30 | 7.85 | 7.92 | 4.22 | 17.10 | 16.59 | 16.53 | 20.19 | 20.37 | 20.77 | 19.26 | 18.54 | 18.11 | 17.69 | 17.52 | 17.01 | 16.57 | 3.57 | 4.34 | 4.15 |
ROA % |
7.27 | 6.60 | 3.40 | 5.14 | -0.42 | 5.52 | 3.42 | 2.75 | 2.09 | 3.94 | 2.03 | 2.08 | 4.27 | 4.39 | 2.76 | 3.93 | 3.89 | 7.04 | 5.52 | 9.04 | 10.78 | 12.19 | 9.04 | 11.65 | 10.67 | 10.24 | 8.94 | 10.88 | 12.11 | 13.32 | 12.06 | 10.49 | 10.20 | 9.80 | 13.05 | 13.91 | 14.16 | 14.38 | 14.65 | 12.70 | 12.53 | 12.36 | 12.06 | 13.46 | 5.18 | 4.76 | 4.65 | 2.64 | 10.61 | 10.68 | 11.08 | 13.66 | 13.90 | 14.28 | 13.35 | 13.13 | 13.11 | 13.08 | 13.17 | 13.02 | 12.84 | 2.68 | 3.50 | 3.27 |
DSO |
57.4 | 57.3 | - | 57.1 | 62.7 | 68.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
1.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
19.5 | 18.9 | - | 19.8 | 15.7 | 19.2 | - | 18.6 | 17.2 | 19.9 | - | 16.5 | 16.1 | 16.7 | - | 8.2 | 7.7 | 15.7 | - | 12.7 | 13.4 | 13.6 | - | 13.0 | 12.3 | 12.6 | - | 12.5 | 13.1 | 13.0 | - | 12.8 | 12.9 | 13.2 | - | 15.9 | 16.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 57.3 | - | 57.1 | 62.7 | 68.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 38.3 | - | 37.3 | 47.0 | 48.9 | - | -18.6 | -17.2 | -19.9 | - | -16.5 | -16.1 | -16.7 | - | -8.2 | -7.7 | -15.7 | - | -12.7 | -13.4 | -13.6 | - | -13.0 | -12.3 | -12.6 | - | -12.5 | -13.1 | -13.0 | - | -12.8 | -12.9 | -13.2 | - | -15.9 | -16.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Healthcare Services Group, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
China
Germany
Britain
